日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modified hTERT treatment ameliorates pressure overload-induced heart failure.

改良的hTERT治疗可改善压力负荷过重引起的心力衰竭。

Zhao Yinlong, Bao Xiaolu, Xiong Weiyao, Wan Xin, Yu Qingying, Wang Teng, Chang Andrew C H, Liu Yangyang, Wang Yanqiu, Shang Ching, Wu Min, Ashley Euan A, Lei Ming, Zhang Junfeng, Wu Yueheng, Han Wei, Chang Alex C Y

Multimodal data-based graph convolutional networks for predicting outcomes in ovarian cancer receiving neoadjuvant chemotherapy

基于多模态数据的图卷积网络预测接受新辅助化疗的卵巢癌患者的预后

Zhang, Shimin; Liu, Yinlong; Liu, Zhuonan; Li, Xinyue; Wang, Guan; Yang, Zhuo; Liu, Yutong; Li, Meiyao; Wang, Jiarui; Zhang, Jiage; Chen, Bosinan; Liu, Jingyi; Zhang, Yi; Song, Jiangdian; Zhou, Xin

Clinician-deployable deep hypergraph model integrating clinical and CT radiomics predicts immunotherapy outcomes in NSCLC

临床医生可部署的深度超图模型整合了临床和CT放射组学数据,可预测非小细胞肺癌的免疫治疗效果。

Song, Jiangdian; Nie, Qiang; Wang, Siqi; An, Taixue; Li, Xiao; Liu, Yinlong; Wang, Hairui; Shi, Ruichuan; Wang, Lu; Lin, Meiyin; Pan, Xuanda; Li, Xin; Hou, Qiuyang; Xu, Nan; Guo, Xiaoyu; Mao, Yuqiang; Liu, Bin; Qu, Xiujuan; Liu, Jian-Hua; Zhong, Wen-Zhao

Preclinical development of [(18)F]TAAR1-2203 as a PET radioligand for imaging TAAR1 expression and receptor occupancy

[(18)F]TAAR1-2203 作为 PET 放射性配体用于 TAAR1 表达和受体占有率成像的临床前开发

Haider, Achi; Xiao, Zhiwei; Chen, Jiahui; Pfister, Stefanie K; Zhou, Xin; Li, Yinlong; Chaudhary, Ahmad; Zhao, Chunyu; Rong, Jian; Paehler, Axel; Mohr, Susanne; Norcross, Roger D; Honer, Michael; Mu, Linjing; Gobbi, Luca; Schibli, Roger; Hoener, Marius C; Liang, Steven H

Reactive oxygen species in skin diseases: pathogenic mechanisms and nanomaterial-based therapeutic strategies

皮肤疾病中的活性氧:致病机制和基于纳米材料的治疗策略

Yan, Qi; Zheng, Yu; Chen, Long; Ma, Hongmin; Ding, Chao; Pang, Xiaoxiao; Xia, Tingting; Wei, Jingyan; Zhang, Yinlong; Xu, Guoxin

6,7-Dihalo-Benzothiadiazines as Potent and Selective AMPA Receptor Modulators for Cognitive Enhancement and Neuroprotection

6,7-二卤代苯并噻二嗪类化合物作为强效且选择性的AMPA受体调节剂,可用于认知增强和神经保护

Li, Yinlong; Yuan, Hongjie; Liang, Steven H

SAR-Guided Scaffold Innovation of Selective V(2)R Antagonists: Therapeutic Frontiers in ADPKD

基于构效关系的选择性V(2)R拮抗剂骨架创新:ADPKD的治疗前沿

Shi, Haofeng; Li, Yinlong; Liang, Steven H

Radiosynthesis and Preclinical Evaluation of a Novel (11)C‑Labeled Pyrazolopyrimidine Derivative for Positron Emission Tomography Imaging of Phosphodiesterase 2A

一种新型(11)C标记的吡唑并嘧啶衍生物的放射合成及临床前评价,用于磷酸二酯酶2A的正电子发射断层扫描成像

Li, Yinlong; Mori, Wakana; Song, Zhendong; Yamasaki, Tomoteru; Zhao, Taoqian; Chen, Jiahui; Zhang, Yiding; Zhou, Xin; Xie, Lin; Kokufuta, Tomomi; Hu, Kuan; Hu, Qilong; Fujinaga, Masayuki; Li, Xiaoyan; Kumata, Katsushi; Li, Chongjiao; Sun, Zhenkun; Gao, Yabiao; Hoyle, Danielle E; Patel, Jimmy S; Yuan, Hongjie; Zhang, Ming-Rong; Liang, Steven H

Radiosynthesis and Evaluation of (18)F‑Labeled Deuterated Radioligand for Positron Emission Tomography Imaging of Cholesterol 24-Hydroxylase

合成和评价用于胆固醇24-羟化酶正电子发射断层扫描成像的(18)F标记氘代放射性配体

Li, Yinlong; Song, Zhendong; Shi, Haofeng; Zhao, Taoqian; Chen, Jiahui; Zhou, Xin; Hu, Qilong; Li, Xiaoyan; Meng, Lingxin; Song, Ruihu; Sun, Zhenkun; Li, Chongjiao; Haider, Achi; Yuan, Hongjie; Liang, Steven H

Selective 7‑Azaindole Modulators Targeting Fyn and GSK-3β for Dual-Target Neuromodulation

选择性7-氮杂吲哚调节剂靶向Fyn和GSK-3β用于双靶点神经调控

Shi, Haofeng; Li, Yinlong; Liang, Steven H